Drug intelligence / Profile preview

Yaz

Development stage
Approved
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Yaz is a combined oral contraceptive (COC) containing the progestin drospirenone (3 mg) and the synthetic estrogen ethinyl estradiol (0.02 mg). Drospirenone is a spironolactone analogue that possesses unique anti-mineralocorticoid and antiandrogenic properties, which distinguish it from other synthetic progestins. The drug works primarily by suppressing ovulation through the inhibition of gonadotropin secretion (FSH and LH). Yaz is FDA-approved for contraception, the treatment of moderate acne vulgaris, and the treatment of premenstrual dysphoric disorder (PMDD) in the general population. This specific clinical trial, led by St. Joseph's Healthcare Hamilton, evaluates the safety and efficacy of Yaz for treating PMDD specifically in women with comorbid bipolar disorder, a population that is frequently understudied and often excluded from standard hormonal contraceptive trials.

Brand names
Yaz
Other names
drospirenone + ethinyl estradioldrospirenone/ethinyl estradiol
02

Targets

PR (Progesterone receptor)ER (Estrogen receptor)AR (Adrenergic receptors)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on Yaz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaz.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call